YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Mastalgia Prevalence and Effects of Methylxanthine Contain Foods on Symptoms of Mastalgia

No Thumbnail Available

Date

2008

Journal Title

Journal ISSN

Volume Title

Publisher

Galenos Yayincilik

Abstract

Objective: To evaluate the prevalance of mastalgia and, the effects of methylxsanthine containing food on the frequency and severity of mastalgia. Institution: Obstetrics and Gynecology Clinic of Yuzuncu Yil University Medical Faculty and the First and Forth Healthcare Centers, Van Material and method: 1795 women, aged between 15-44 years were interviewed for the complaints of mastalgia. The severity of mastalgia was scored as mild, moderate and severe. The severity of mastalgia were also questioned for the consumption frequency of tea, coffee, cola and chocolate. Results: Of these 1795 women, 797 (44.4 %) have breast pain, while 998(55.6 %) have not breast pain, 539 (67.6 %) of these 797 women with breast pain have mild, 157 (19.7 %) have moderate, 101 (12.6 %) have severe mastagia. Mastalgia occurred in 324 (40.6 %) during menstrual time, in 281(35.3 %) during luteal phase, while in 192 (24 %) was reported during proliferative phase. There was no significant relation between breast pain and coffee, cola, chocolate consumption frequency. There was not significant relation between breast pain and coffee, cola, chocolate consumption frequency (p=0.061). Conclusion: The prevalence of mastalgia in our region was similar to the reports in the literature. The complaint of breast pain was much higher in women drinking tea than women not drinking tea, but this difference was not statistically different. There was not any statistically significant relation between breast pain and coffee, cola, chocolate consumption.

Description

Keywords

Chocalate, Coffee, Cola, Mastalgia, Prevalence

Turkish CoHE Thesis Center URL

WoS Q

N/A

Scopus Q

Q3

Source

Volume

5

Issue

3

Start Page

207

End Page

211